Azilsartan Suppresses Osteoclastogenesis and Ameliorates Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species Production and Activating Nrf2 SignalingBin Pan, Dengwei He, Jiawei Gao et al.|Frontiers in Pharmacology|2021Cited by 21
MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1Bin Pan, Dengwei He, Jiawei Gao et al.|Cell Death Discovery|2022Cited by 20
Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-κB signaling pathwayKangtao Jin, Dengwei He, Shijie Liu et al.|Biochemical Pharmacology|2021Cited by 17